Clomiphene Citrate 50 mg: Clomid and Generic Product Guide
Clomiphene citrate is a prescription medication in the United States. Current U.S. labeling for both Clomid and generic clomiphene citrate products states “Rx Only,” and current products are supplied as 50 mg oral tablets.
Clomiphene citrate, Clomid and generic products
Clomiphene citrate is the active ingredient. Clomid is a branded clomiphene citrate product. Current DailyMed labeling identifies Clomid 50 mg tablets distributed by Cosette Pharmaceuticals, Inc., with manufacturing by Par Formulations. This is useful because Clomid is not merely a historical name in current product research: a current U.S. product label remains available.
Generic clomiphene citrate products also have current U.S. labeling. DailyMed currently lists products from multiple packagers or labelers, including Appco Pharma, Rising Pharma Holdings, Accord Healthcare, Advagen Pharma, ANI Pharmaceuticals, Acetris Pharma Holdings and Camber Pharmaceuticals. The exact supplier list can change as products enter or leave the market, so a prescription for “clomiphene citrate 50 mg” should not be assumed to identify one manufacturer permanently.
What the 50 mg strength means
Current Clomid and generic labels describe 50 mg tablets for oral use. Different products can differ in tablet appearance, imprint, packaging, inactive ingredients, NDC and the company responsible for labeling or distribution while containing the same labeled amount of clomiphene citrate. Those differences are important when a patient is trying to identify a refill, compare an unfamiliar tablet with a previous product, or resolve an insurance claim tied to a particular NDC.
A patient should not infer that a package offered on a website is FDA-approved merely because it says “clomiphene 50 mg.” Product identity is established by the regulatory application, labeler/manufacturer information and U.S. drug labeling, not by the active-ingredient name alone.
Prescription status and U.S. use
Current U.S. clomiphene products are prescription drugs. The Clomid label describes the drug as an ovulatory stimulant and contains detailed criteria, warnings and limitations for treatment. Treatment requires clinical evaluation rather than self-directed use.
Clomiphene is also discussed online in contexts outside its FDA-labeled use, including use in men. Such discussion does not convert an off-label use into an FDA-approved indication. Product research should keep that distinction clear rather than presenting clomiphene as a general testosterone, bodybuilding or self-treatment product.
Current product examples
DailyMed’s current records illustrate why “generic clomiphene” is a product category rather than one single package. An Acetris Pharma Holdings label, issued in 2026, lists a 50 mg tablet under ANDA 216739 and identifies Appco Pharma LLC in manufacturing operations. A separate current Camber Pharmaceuticals label lists a 50 mg clomiphene citrate tablet under ANDA 220673, manufactured by Ascent Pharmaceuticals. Other current DailyMed results identify additional labelers.
These examples are useful for verifying that FDA-regulated generic products exist, but they do not establish that every pharmacy has every labeler in stock. Wholesaler availability can change and pharmacies may receive an equivalent product from a different manufacturer or distributor.
Cost, insurance and pharmacy verification
For a patient comparing clomiphene products, the most useful pre-purchase questions are practical: Is the prescription for 50 mg tablets? Which NDC and labeler would be dispensed? Is the product covered by the patient’s plan? Does the plan require prior authorization or impose quantity limits? Is the quoted amount a cash price or an insurance copay?
Contact the pharmacy to confirm current availability, product identity and coverage for a specific prescription.
Clomid is currently represented alongside multiple generics
Current DailyMed results are useful because they show both the Clomid brand record and multiple generic clomiphene citrate records at the same time. This avoids two product-identification errors: Clomid should not be treated as merely an obsolete historical name, and generic clomiphene should not be treated as a single anonymous product.
For example, the current Clomid label identifies Cosette Pharmaceuticals as distributor and a 50 mg tablet under an ANDA. Separate current generic records list different application numbers and labelers. The presence of several records is evidence of a multi-manufacturer U.S. market, but it is not evidence that every listed product is immediately obtainable from every pharmacy.
Product verification is more useful than package-shopping language
For prescription clomiphene, useful pre-purchase questions focus on the active ingredient, 50 mg strength, oral tablet dosage form, labeler or manufacturer, NDC, prescription status and whether the pharmacy can source the exact or an equivalent product. If a patient has received a specific manufacturer before, the pharmacist can check whether that product remains available or whether another approved supplier is being used.
Product verification also avoids unsupported claims about fertility outcomes. The product label is the authority for approved use and safety information; pharmacy research can clarify what is being obtained and how to verify it.
For broader patient-facing information, see Medication & Pharmacy Resources.